(function(){var loadHandler=window['sl_{E3D701B7-9456-41DA-AA5D-ED55FDEB2C76}'];loadHandler&&loadHandler(7, '<div id="spr0_347edfaf"><div id="spr1_347edfaf" class="kern slide"><img id="img4_347edfaf" src="data/img1.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_347edfaf" class="kern slide"><img id="img0_347edfaf" src="data/img2.png" width="721.48" height="100.8" alt="" style="left:-1.48px;"/><div id="svg1_347edfaf" style="left:-1.48px;top:99.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#c76c02" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><div id="svg2_347edfaf" style="left:-1.48px;top:0.523px;"><svg width="722" height="4" viewBox="0 0 722 4"><path fill="#2e3546" d="M0,0 h721.48 v3.6 h-721.48 Z"/></svg></div><img id="img1_347edfaf" src="data/img3.png" width="721.48" height="43.101" alt="" style="top:496.899px;"/><div id="spr3_347edfaf" style="left:657.715px;top:499.855px;"><img id="img2_347edfaf" src="data/img4.png" width="56" height="36" alt="CHRC logo_with text.psd" style="left:-0.105px;top:-0.177px;"/></div><div id="spr4_347edfaf" style="top:14.283px;"><div style="width:0px;"><span id="txt0_347edfaf" data-width="678.712891" style="left:21.692px;top:4.901px;">Treatment and LDL-C Management in Patients Diagnosed with</span></div><div style="width:0px;"><span id="txt1_347edfaf" data-width="634.210938" style="left:44.147px;top:38.501px;">Clinical Atherosclerotic Cardiovascular Disease in Alberta</span></div></div><div id="spr5_347edfaf" style="left:4.43px;top:506.2px;"><div style="width:0px;"><span id="txt2_347edfaf" class="nokern" data-width="146.478516" style="left:7.2px;top:4.096px;">Chen et al. Can J Cardiol. 2019. 35:884-891.</span></div></div><div id="spr6_347edfaf" style="left:518.316px;top:171.759px;"><div style="width:0px;"><span id="txt3_347edfaf" class="nokern" data-width="131.482422" style="left:22.39px;top:4.371px;">Mean time to second test:</span></div><div style="width:0px;"><span id="txt4_347edfaf" class="nokern relpos" data-width="22.346680" style="left:44.33px;top:21.05px;">276 </span><span id="txt5_347edfaf" class="nokern relpos" style="left:44.325px;top:21.05px;">±</span><span id="txt6_347edfaf" class="nokern relpos" data-width="51.707031" style="left:44.32px;top:21.05px;"> 217 days</span></div></div><div id="spr7_347edfaf" style="left:347.975px;top:158.046px;"><img id="img3_347edfaf" src="data/img17.png" width="381" height="324" alt="" style="left:-0.072px;top:0.177px;"/></div><div id="spr8_347edfaf" style="left:535.765px;top:458.419px;"><div style="width:0px;"><span id="txt7_347edfaf" class="nokern relpos" data-width="12.512932" style="left:26.129px;top:4.287px;">µ </span><span id="txt8_347edfaf" class="nokern relpos" style="left:26.124px;top:4.206px;">=</span><span id="txt9_347edfaf" class="nokern relpos" style="left:26.119px;top:4.287px;"> </span><span id="txt10_347edfaf" class="nokern relpos" data-width="15.049805" style="left:26.114px;top:4.206px;">1.9 </span><span id="txt11_347edfaf" class="nokern relpos" data-width="53.168457" style="left:26.109px;top:4.206px;">± 0.8 mmol/L</span></div></div><div id="spr9_347edfaf" style="left:399.545px;top:458.054px;"><div style="width:0px;"><span id="txt12_347edfaf" class="nokern relpos" data-width="12.512932" style="left:18.486px;top:4.287px;">µ </span><span id="txt13_347edfaf" class="nokern relpos" data-width="22.827148" style="left:18.481px;top:4.206px;">= 2.2 </span><span id="txt14_347edfaf" class="nokern relpos" data-width="53.168457" style="left:18.476px;top:4.206px;">± 1.0 mmol/L</span></div></div><div id="spr10_347edfaf" style="left:347.975px;top:110.913px;"><div style="width:0px;"><span id="txt15_347edfaf" data-width="336.827148" style="left:11.188px;top:4.25px;">LDL-C levels for patients on any lipid-lowing therapy who had</span></div><div style="width:0px;"><span id="txt16_347edfaf" data-width="235.094727" style="left:62.062px;top:21.05px;">both index and follow-up tests (n = 91,841).</span></div></div><div id="spr11_347edfaf" style="left:24.904px;top:180.683px;"><div style="width:0px;"><span id="txt17_347edfaf" class="nokern relpos" style="left:7.2px;top:5.005px;"></span><span id="txt18_347edfaf" class="relpos" data-width="231.424805" style="left:21.465px;top:4.592px;">Among patients on statin/non-statin</span></div><div style="width:0px;"><span id="txt19_347edfaf" data-width="222.020508" style="left:29.7px;top:26.192px;">therapy, n=91,841 had an index &amp;</span></div><div style="width:0px;"><span id="txt20_347edfaf" data-width="137.812500" style="left:29.7px;top:47.792px;">follow-up LDL-C test.</span></div></div><div id="svg4_347edfaf" style="left:24.904px;top:282.446px;"><svg width="303" height="139" viewBox="0 0 303 139"><path fill="#d2eefa" d="M0,0 h302.214 v138.136 h-302.214 Z"/></svg></div><div id="spr12_347edfaf" style="left:24.904px;top:282.446px;"><div style="width:0px;"><span id="txt21_347edfaf" class="nokern relpos" style="left:7.2px;top:5.043px;"></span><span id="txt22_347edfaf" class="relpos" data-width="194.493164" style="left:21.465px;top:4.629px;">48.5% of these patients were </span><span id="txt23_347edfaf" class="relpos" data-width="22.948242" style="left:21.46px;top:4.436px;">not</span></div><div style="width:0px;"><span id="txt24_347edfaf" class="relpos" data-width="68.097656" style="left:29.7px;top:26.036px;">achieving</span><span id="txt25_347edfaf" class="relpos" data-width="173.531250" style="left:29.695px;top:26.229px;"> LDL-C &lt;2.0 mmol/L at the</span></div><div style="width:0px;"><span id="txt26_347edfaf" data-width="100.924805" style="left:29.7px;top:47.792px;">index test (left);</span></div><div style="width:0px;"><span id="txt27_347edfaf" class="nokern relpos" style="left:7.2px;top:69.843px;"></span><span id="txt28_347edfaf" class="relpos" data-width="82.045898" style="left:21.465px;top:69.429px;">36.6% were </span><span id="txt29_347edfaf" class="relpos" data-width="99.254883" style="left:21.46px;top:69.236px;">not achieving </span><span id="txt30_347edfaf" class="relpos" data-width="75.884766" style="left:21.455px;top:69.429px;">LDL-C &lt;2.0</span></div><div style="width:0px;"><span id="txt31_347edfaf" data-width="243.676758" style="left:29.7px;top:90.992px;">mmol/L or 50% reduction at follow-up</span></div><div style="width:0px;"><span id="txt32_347edfaf" data-width="42.644531" style="left:29.7px;top:112.592px;">(right).</span></div></div></div></div>');})();